Joe Ganley

home / authors / joe-ganley

Joe Ganley is vice president, government and regulatory affairs at athenahealth in Wellesley, Massachusetts.

Articles

Let’s Stop Talking About Interoperability and Just Make it Work

Let’s Stop Talking About Interoperability and Just Make it Work

Joe Ganley
April 24th 2023

Interoperability was theme at the Healthcare Information and Management Systems Society (HIMSS) meeting last week in Chicago. How can all that talk and aspiration be turned into action?

Read More

The Signals on Data Privacy Are Mixed. Healthcare's Future Depends on Which Ones Are Listened To.

The Signals on Data Privacy Are Mixed. Healthcare's Future Depends on Which Ones Are Listened To.

Joe Ganley
April 20th 2022

Big tech and its access to our data is a juicy target. But policy makers need to be careful or they will upend interoperability and turn back the clock on American healthcare.

Read More

Latest Updated Articles

Screenshot of an interview with Harmony Garges, MD
Published: October 19th 2024 | Updated: October 22nd 2024
Real-World Evidence of Apretude Highlights High Adherence, Effectiveness as PrEP | ID Week 2024
conceptual illustration of schizophrenia | Image credit: ©eyetronic stock.adobe.com
Published: October 17th 2024 | Updated: October 22nd 2024
More Treatment Options for Schizophrenia, More Decisions About Which One to Choose | AMCP Nexus 2024
woman on floor looking sad silhouette | Image credit: @kittiplan stock.adobe.com
Published: October 10th 2024 | Updated: October 22nd 2024
Mental Health May Play a Role in Vitiligo Treatment Efficacy, Study Shows
magann-stock.adobe.com
Published: October 16th 2024 | Updated: October 22nd 2024
Disparities Exist in Use of PrEP to Prevent HIV | ID Week 2024
New Study Finds Correlation Between Race and Lung Cancer Testing
Published: October 3rd 2024 | Updated: October 22nd 2024
New Study Finds Correlation Between Race and Lung Cancer Testing
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, an expert on myelofibrosis
Published: August 14th 2024 | Updated: October 22nd 2024
JAK Inhibitors and Myelofibrosis Management: A Review of Current Treatments
© 2024 MJH Life Sciences

All rights reserved.